LSAG
ABBV icon

Lake Street Advisors Group’s AbbVie ABBV Stock Holding History

Lake Street Advisors Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$10.9M Buy
61,572
+18,231
+42% +$3.35M 0.5% 36
2024
Q3 		$8.56M Buy
43,341
+5,311
+14% +$991K 0.4% 44
2024
Q2 		$6.52M Sell
38,030
-429
-1% -$71.1K 0.31% 53
2024
Q1 		$7M Buy
38,459
+371
+1% +$63.9K 0.33% 51
2023
Q4 		$5.9M Sell
38,088
-31
-0.1% -$4.52K 0.3% 54
2023
Q3 		$5.68M Sell
38,119
-794
-2% -$117K 0.34% 50
2023
Q2 		$5.24M Buy
38,913
+1,339
+4% +$196K 0.29% 53
2023
Q1 		$5.99M Buy
37,574
+1,764
+5% +$270K 0.37% 45
2022
Q4 		$5.79M Sell
35,810
-921
-3% -$141K 0.38% 47
2022
Q3 		$4.93M Sell
36,731
-1,152
-3% -$165K 0.36% 47
2022
Q2 		$5.8M Buy
37,883
+412
+1% +$63K 0.41% 42
2022
Q1 		$6.07M Buy
37,471
+3,644
+11% +$529K 0.39% 39
2021
Q4 		$4.58M Buy
33,827
+252
+0.8% +$29.8K 0.29% 54
2021
Q3 		$3.62M Buy
33,575
+24,305
+262% +$2.78M 0.39% 44
2021
Q2 		$1.07M Buy
9,270
+248
+3% +$27.9K 0.08% 105
2021
Q1 		$976K Sell
9,022
-9,405
-51% -$1.01M 0.08% 103
2020
Q4 		$1.97M Buy
18,427
+9,598
+109% +$922K 0.16% 62
2020
Q3 		$773K Sell
8,829
-73
-0.8% -$6.87K 0.07% 109
2020
Q2 		$874K Buy
8,902
+1,025
+13% +$90.2K 0.09% 97
2020
Q1 		$600K Buy
7,877
+2,481
+46% +$211K 0.07% 102
2019
Q4 		$478K Buy
5,396
+232
+4% +$19.3K 0.05% 123
2019
Q3 		$366K Sell
5,164
-261
-5% -$17.9K 0.04% 127
2019
Q2 		$395K Sell
5,425
-360
-6% -$28.3K 0.04% 119
2019
Q1 		$466K Buy
5,785
+381
+7% +$31.2K 0.05% 112
2018
Q4 		$498K Sell
5,404
-697
-11% -$61.3K 0.06% 91
2018
Q3 		$577K Sell
6,101
-2,390
-28% -$227K 0.06% 83
2018
Q2 		$787K Buy
8,491
+345
+4% +$33.7K 0.08% 106
2018
Q1 		$771K Buy
8,146
+183
+2% +$20.1K 0.09% 88
2017
Q4 		$770K Buy
+7,963
New +$750K 0.09% 94

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Lake Street Advisors Group's ABBV Position: Q4 2024 in Review

Lake Street Advisors Group increased its AbbVie (ABBV) stake by 42% in Q4 2024, buying an estimated $3.35M and bringing the position to 61,572 shares worth $10.9M. The position accounts for 0.5% of the portfolio, ranked #36.

Lake Street Advisors Group first reported a position in ABBV in Q4 2017 and has held it in 29 quarters since. 3,745 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Lake Street Advisors Group held 61,572 shares of AbbVie worth $10.9M as of Q4 2024.
  • Lake Street Advisors Group bought 18,231 AbbVie shares in Q4 2024, an estimated $3.35M.
  • AbbVie made up 0.5% of Lake Street Advisors Group's portfolio in Q4 2024, its #36 holding.
  • Lake Street Advisors Group first reported a position in AbbVie in Q4 2017 and has held it in 29 quarters since.
  • 3,745 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.